[Pathology of Cushing's syndrome].
D000239:Adenoma, Acidophil / Q000150:complications / Q000473:pathology; D000237:Adenoma, Basophil / Q000150:complications; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000473:pathology; D000324:Adrenocorticotropic Hormone / Q000009:adverse effects / Q000378:metabolism; D002277:Carcinoma / Q000150:complications / Q000473:pathology; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D003480:Cushing Syndrome / Q000139:chemically induced / Q000209:etiology / Q000473:pathology*; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D006965:Hyperplasia / Q000150:complications; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D010911:Pituitary Neoplasms / Q000150:complications
D005938:Glucocorticoids; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone
Zur Pathologie des Cushing-Syndroms.